Background. P-Adrenergic blockade is known to improve the survival of patients after acute myocardial infarction and to reduce myocardial infarct size in experimental coronary occlusion. However, the effects of P-blockade on global and regional left ventricular (LV) remodeling have not been characterized after coronary occlusion with reperfusion. In rats subjected to coronary occlusion and reperfusion, we have demonstrated beneficial effects of reperfusion in sedentary rats with a hypertrophic response to exercise in the surviving outer wall of the infarcted zone, and in this study we investigated whether such remodeling is modified by P-blockade in both sedentary and exercised rats.
A widely used approach in secondary prevention after acute myocardial infarction, f3-adrenergic blockade has been shown to reduce late mortality and reinfarction in large clinical trials.1-6 In patients with acute myocardial infarction who have received thrombolytic agents, no effect of ,8-blockade on l-year mortality has been demonstrated, although there was some benefit on recurrent ischemic events. 7 The effects of p-blockade on left ventricular (LV) remodeling in the setting of thrombolytic treatment for myocardial infarction have not been characterized.
In experimental studies in rats subjected to permanent coronary occlusion, Fishbein et a18 reported that propranolol treatment caused dilation of the left ventricle and blunted myocyte hypertrophy, suggesting possible deleterious effects of p8-adrenergic blockade on the left ventricle in this setting. However, permanent coronary occlusion in the rat is known to produce transmural infarction,9,10 whereas in species that develop a coronary collateral circulation, such as the dog and some human subjects in the setting of spontaneous or induced thrombolysis,11 nontransmural infarction occurs. Therefore, because of the limited applicability of the rat model of permanent coronary occlusion to the setting of reperfusion after coronary occlusion, we have developed and characterized a model of nontransmural myocardial infarction in rats by subjecting them to 45 minutes of coronary occlusion followed by reperfusion. In this model, substantial epicardial sparing was demonstrated in sedentary rats compared with those with permanent coronary occlusion, and swimming exercise induced additional hypertrophy of the outer wall in the infarcted region .12 In addition to attenuating compensatory hypertrophy after experimental transmural myocardial infarction,8 P-blockade also can suppress isoproterenol-induced myocardial hypertrophy13 and hypertrophy in spontaneously hypertensive rats.14'15 However, the effects of 3-blockade on LV remodeling in the setting of experimental coronary occlusion with reperfusion have not been examined. Accordingly, in this study, the effects of 3-adrenergic blockade with propranolol on LV morphology were investigated in the rat model of coronary artery occlusion followed by reperfusion.12 In addition, since exercise training is used in rehabilitation after acute myocardial infarction and has been shown in the rat reperfusion model to produce regional hypertrophy,12 we also undertook to study the influence of 3-blockade on the effects of exercise in reperfused hearts.
Methods
The animals in this study were handled according to the animal welfare regulations of the American Heart Association and the University of California San Diego, and the experimental protocol was approved by the Animal Subjects Committee of this institution.
Animal Model and Surgical Preparation
Female Sprague-Dawley rats weighing 250-300 g were anesthetized with a mixture of ketamine hydrochloride (100 mg/kg body wt i.p.), xylazine (10 mg/kg i.p.), and morphine sulfate (5 mg/kg i.p.). Forty-five minutes of coronary occlusion followed by reperfusion was performed as described elsewhere.12 Briefly, after adequate anesthesia, all animals were placed in the supine position on a table heated by circulating warm water, intubated, and ventilated under positive pressure with a rodent ventilator (model 683, Harvard Apparatus). Under a dissecting microscope, a left thoracotomy was performed in the fourth intercostal space, and the pericardium was opened. The left coronary artery (which is intramural) was encircled together with a band of myocardium between the left atrial appendage and right ventricular outflow tract with a curved needle and 6-0 silk suture.
The artery was then occluded, and reperfusion was performed after 45 minutes by cutting the ligature around the left coronary artery. A small piece of plastic foam was tied between the ligature and myocardium to minimize direct injury to the myocardium and artery and to facilitate cutting of the ligature. A 
Experimental Protocol
After surgery, animals were caged in proportion to size, given water and standard rat chow ad libitum, and housed in a climate-controlled environment subjected to 12-hour light/dark cycles. Five days after coronary reperfusion, 87 rats were randomly assigned to one of the following four groups: propranolol-treated sedentary rats (n=20), propranolol-treated exercised rats (n=21), untreated sedentary rats (control group) (n=21), and untreated exercised rats (swimming) (n=25). The latter two groups are also reported as part of another study,12 which also included preparation of sham-operated animals and animals with permanent coronary ligation. Propranolol (Sigma Chemical Co., St. Louis, Mo.) was administered ad libitum in drinking water at a concentration of 750 mg/l, and the water bottle was changed three times weekly.
Dose-response tests of isoproterenol on heart rate were performed in 14 rats (eight untreated, six propranolol-treated) just before termination of the experiments to confirm adequate 13-adrenergic blockade. Under anesthesia, the right jugular vein was cannulated with a polyethylene catheter (PE 50), and an ECG was monitored and recorded (Gould Brush 200 recorder). After heart rates were recorded during a control period with saline infusion, isoproterenol was given continuously with an infusion pump at increasing doses of 0.05, 0.1, 0.25, 0.5, 1, and 4 jig/min. Dose-response curves from untreated and propranolol-treated groups showed a competitive antagonist effect with significant difference between the two groups (p<0.05, ANOVA) ( Figure 1 ). The swimming exercise began 5 days after surgery with a single 15-minute swimming period daily. The duration of the exercise period was increased by 5 min/day up to 60 minutes and then continued 7 days a week for 3 weeks. Rats swam in groups of five to 10 animals in a 50-cm-deep plastic tub containing water heated to 33-35°C. The experimental protocol after randomization was completed in 83 of 87 rats (three rats in the untreated exercised group and one in the propranolol-treated exercised group died during swimming exercise).
Postmortem and Histological Preparations
Twenty-six days after surgery, the rats were anesthetized with the same anesthesia as described above for the initial surgery and euthanized as described elsewhere.12 After the thorax was opened, the heart was perfused retrogradely from the aorta at a constant pressure of 60 mm Hg and a cavity LV pressure of 10 mm Hg and fixed for 20-30 minutes with 10% phosphate-buffered formalin. 12 After hardening, the heart was excised and immersed into 10% buffered formalin solution, and 24 hours later, the right and left ventricles including the interventricular septum were dissected, separated, and weighed. The heart weights were normalized by the length of tibia,16 as well as by body weight as described elsewhere. 12 After 2 days or more in 10% buffered formalin solution, the whole left ventricle was embedded in paraffin. Transverse serial sections 25 gm thick were cut, and every 40th section from the apex to the base (every 1 mm) was mounted and stained with Milligan's trichrome.
Morphometric Analyses
Measurements were performed on two midventricular transverse slices (5 and 6 mm from the apex) and averaged, since those measurements have been shown to reflect data from all slices.12 All slides were analyzed blindly, and interobserver variation for such measurements was also demonstrated to be acceptably small. 12 The slides were projected with a microprojector (Jena, Germany) with magnification of x17.3, and measurements were made by computerized planimetry. The endocardial and epicardial outlines of the LV slice were traced on paper, and the area of the infarcted zone, including the scarred area and spared epicardial and endocardial areas, the area of the LV cavity, the area of the total myocardial ring, and the average thicknesses of noninfarcted septal and infarcted anterior walls, was measured as described elsewhere. 12 The percent infarct size on each slice was estimated from the ratio of the infarct area to the total area of the LV ring and expressed as percentage of total ring area. Transmurality of the infarct was defined as the ratio of the infarct area to the area of the total infarct region, which was subtended by radii touching the lateral margins of the infarct (sum of infarct, epicardial, and endocardial areas). The thickness of the interventricular septum was considered representative of the noninfarcted wall. The ratios of the LV dimension to the average thickness of the infarcted and the noninfarcted walls were calculated to estimate relative changes of regional LV diastolic wall stress according to the law of Laplace,16,18 since the hearts were fixed at a common distending pressure. Statistics All values are expressed as mean±+SD. A two-way ANOVA was used to examine the effects of propranolol (untreated versus treated) and exercise (sedentary ver-measures of morphological features. If there was a significant interaction between drug treatment and nontreatment or between exercise and no exercise, further examination of selected pairwise comparisons was undertaken. We hypothesized that propranolol treatment would reduce or prevent the morphological changes shown in another study'2 to be induced by exercise, and the Newman-Keuls test was used to test for such differences. When there was no interaction effect, it can be assumed that any significant effect of exercise was the same in treated and untreated animals. Values of p<0.10 were considered significant for interaction effects, and values ofp<0.05 were considered statistically significant for main effects and for post hoc tests.
Results
Of the 83 rats that completed the experimental protocol, one heart in the untreated sedentary group, one in the untreated exercised group, one in the propranolol-treated sedentary group, and two in the propranolol-treated exercised group were excluded when it appeared that minor infarction (<5%) was due to suture injury and not to experimentally induced occlusion. Therefore, 78 hearts were used for the analysis. Data from the untreated animals randomized to sedentary and exercise groups, to which the propranololtreated rats are compared, have been analyzed in detail elsewhere and compared with sham-operated animals and with rats with permanent coronary occlusion.12
Effects of Propranolol on Heart Weights
The left and right ventricular weights and their values normalized by tibial length are summarized in Table 1 . Although trends can be noted for LV weights and LV/tibial length ratios to be slightly lower at rest and after exercise with propranolol, neither treatment nor exercise had statistically significant effect on any of these measurements, and there were no significant interactions.
Effects of Propranolol and Exercise on LV Remodeling
Representative trichome-stained slices of the left ventricle from single untreated sedentary and exercised rats and from propranolol-treated sedentary and exercised rats are shown in Figure 2 . Treatment with propranolol resulted in an increased LV cavity area ( Figure 3 ) and increased LV dimension in both sedentary and exercised groups (Table 2 ). Treatment also reduced the thickness of the noninfarcted and infarcted walls ( Figure 3 ) and increased LV dimension/wall thickness ratios (Table 2) . Total myocardial areas were decreased by propranolol in both sedentary and exercised groups (Table 2) .
Comparing exercised versus sedentary animals in both treated and untreated groups, exercise further increased LV cavity area and LV dimension, reduced wall thickness in the noninfarcted wall, and increased LV dimension/wall thickness ratio in that wall. For these four measures, there was no significant drug/ exercise interaction, so it can be assumed that exercise had about the same effect in treated and untreated animals.
Significant drug/exercise interactions suggested that a differential effect occurred between the untreated exersus exercise) on variables related to heart weight and cised and propranolol-treated exercised rats for total myocardial area, the viable epicardial area of the infarct region, and the total infarct area (epicardial plus endocardial). By the Newman-Keuls test, propranololtreated exercised animals had a significantly lower total myocardial area than untreated exercised animals, and the epicardial-infarct, endocardial-infarct, and epicardial-plus endocardial-infarct areas were also lower. This difference was particularly marked in the epicardial area of the infarct zone (Figure 4 ). All of these variables were at or below those in propranolol-treated sedentary rats, indicating lack of exercise-induced regional hypertrophy ( Table 2) . The absolute infarct (scar) area was not significantly different in the four groups (Table 2) , and the scatter was closely similar ( Figure 5 ). However, since the nonscarred areas of the infarcted wall were reduced in propranolol-treated animals (in both sedentary and exercised groups), the percent transmurality was significantly increased in the treated groups (Table 2) . Also, since the total myocardial areas were reduced by propranolol in both groups, the percent infarct size was increased ( Table 2) . Discussion The findings in the present study indicate that 1adrenergic blockade with propranolol can cause global LV dilation with thinning of both infarcted and noninfarcted walls in reperfused hearts. In addition, propranolol suppressed exercise-induced regional myocardial hypertrophy in the infarcted region. Thus, in nontransmural myocardial infarction, it may be hypothesized that potentially deleterious effects can be produced by f3-adrenergic blockade through inhibition of compensatory and exercise-induced myocardial hypertrophy, leading to LV chamber dilation.
18-Blockade and LV Remodeling
LV dilation, scar thinning, and reduced myocyte hypertrophy in noninfarcted regions were reported by Fishbein et a18 with 5 weeks of propranolol administration commencing 1 day after permanent coronary occlusion in rats. Our study addressed the effects of 3 weeks of f-adrenergic blockade begun somewhat later (5 days) in hearts subjected to coronary artery reperfusion and then randomized to sedentary and exercised conditions to simulate the clinical settings of thrombolysis or acute percutaneous transluminal coronary angioplasty. In this reperfusion model, the transmurality of infarction was found to be much less than with permanent coronary occlusion.12 Nevertheless, P-adrenergic blockade caused dilation of the left ventricle, with thinning of infarcted and noninfarcted walls, both in sedentary and exercised animals, suggesting that such treatment might have suppressed not only exercise-induced hypertrophy but also compensatory hypertrophy in sedentary animals. Evidence for such hypertrophy in both infarcted and noninfarcted regions has been reported in other studies from this laboratory in sedentary dogs. In those studies, myocardial cell hypertrophy greater than that observed in noninfarcted regions was found in surviving cells of the infarcted region at 3 weeks after 2 hours of coronary occlusion with reperfusion.17 LV dilation after acute myocardial infarction is known to be the net result of expansion of the infarcted area and dilation of noninfarcted regions,18 but the exact mechanism of LV dilation produced by 3-adrenergic blockade after infarction remains to be elucidated. Volume overload and increased diastolic wall stress stimulate eccentric LV hypertrophy,18-20 and augmented LV diastolic volume, thinning of the wall, and increased wall tension could result from the decreased contractility and slowed heart rate produced by propranolol. Thinning of the infarcted and noninfarcted walls in our reperfusion model caused by blunted hypertrophy with propranolol might also contribute to elevated wall stress and further chamber dilation.
Attenuation of cardiac hypertrophy without significant change in blood pressure after chronic ,3-adrenergic blockade has been reported in adult spontaneously hypertensive rats,14.21 but (-blockers administered from the time of conception in such rats failed to alter either the progressive rise in arterial pressure or the development of LV hypertrophy.1'5 3-Adrenergic blockade with practolol also was reported not to attenuate experimentally induced LV hypertrophy in abdominal aortabanded rats. 22 However, myocardial hypertrophy after myocardial infarction tends to be of the eccentric type, compared with the concentric type caused by pressure overload, in which 3-adrenergic blockade has shown variable results. Although the myocardial infarction was transmural and therefore different from those in this study, Fishbein and coworkers8 reported suppression of myocardial hypertrophy with longer-term propranolol treatment, with reduced myocyte cross-sectional area and volume. In this study, we report indirect evidence of Propranolol related in part to regional nonuniformity of the observed changes. However, relatively small changes in total LV weight also have been observed in normal rats with longer periods of exercise23 than those used in this study and in our sham-operated rats. 12 
13-Blockade and Exercise
The effect of exercise to further dilate the left ventricle after reperfusion was demonstrated in a previous report concerned with the untreated animals used in this study,'2 and a similar change but with additional dilation was observed after 13-blockade in the present study. Exercise had other significant interactions with propranolol, including a reduction in the total myocardial area in the propranolol-treated exercised group whereas total myocardial area tended to be increased by exercise in untreated rats, it failed to increase and was actually significantly lower than in the propranololtreated sedentary group (Table 2) . Also, propranolol entirely prevented the exercise-induced increase in epicardial and endocardial areas in the infarcted region compared with the untreated group12 (Table 2, Figure 4 ).
The finding that propranolol blocked the effects of exercise to produce an increased myocardial area of the infarcted region has not been reported previously. This indirect evidence for inhibition of exercise-induced regional hypertrophy by propranolol in the present study suggests a possible link between increased sympathetic tone (or f3-adrenergic tone) and myocardial hypertrophy in this model. Considering the potential contribution of myocardial hypertrophy of surviving myocardium in noninfarcted regions to regional and global functional recovery after myocardial infarction,24,25 p3-adrenergic blockade might cause potentially deleterious effects on the recovery of global and regional LV function. Moreover, the combination of 13-adrenergic blockade with exercise after myocardial infarction might be even more detrimental, with exaggeration of the LV dilation caused by propranolol in the sedentary state.
Mechanisms for Inhibition of Hypertrophy
Possible mechanisms for potential suppression of myocardial hypertrophy with .3-adrenergic blockade remain uncertain. It is known that stretch of myocardial cells, which relates to increased wall stress, is a stimulus to activation of the hypertrophic gene program,26 and increased systolic stress also has been suggested to be an initiating factor for the development of myocardial hypertrophy.27 Our finding of increased diastolic cavity size and LV dimension/wall thickness ratios with propranolol treatment in both the infarcted and nonischemic walls (suggesting increased wall stress) provides indirect evidence that diastolic wall stress was elevated. On the other hand, decreased myocardial contractility and lowered blood pressure with chronic P3-blockade, which are particularly prominent during exercise,28 may have reduced peak systolic wall stress. In addition, reduced myocardial blood flow caused by propranolol in nonischemic regions after coronary occlusion29 might have contributed to diminished hypertrophy. Suppression of a direct regulatory effect of cardiac 3-receptors on myocardial hypertrophic events has also been suggested,8 and recently a possible relation between myocardial hypertrophy and ,B-adrenergic stimulation was suggested by Iwaki et al,30 who reported that immediate early gene expression was induced by P-adrenergic stimulation of neonatal rat myocardial cells. Both a-and f3-adrenergic stimulation appear to induce expression of protooncogenes as well as to increase assembly of an individual contractile protein (MLC-2) into organized sarcomeric units.31
Methodological Considerations
Several methodological issues should be mentioned. Because of the complexity of the protocol, we did not attempt to obtain hemodynamic measurements at rest or during exercise in this study. It would be even more compared with the untreated exercised group; thus, desirable to obtain measurements of LV global and regional function, at least under resting conditions, and experimental studies concerned with such analyses in this animal model are now under way. As discussed elsewhere,12 we did not examine cell size because of the morphometric method used and because with only 3 weeks of exercise large numbers of animals would probably be needed to detect cell size differences. 12 Other than reduction of hypertrophy, the other poten- propranolol-treated exercised vs. untreated exercised groups. Significant increase in untreated exercised vs. untreated sedentary rats reported previously.'2 tial mechanism for the observed reductions in regional areas of viable myocardium from those in the absence of a8-blockade is wall thinning caused by LV dilation, although the total myocardial area was diminished by propranolol in sedentary animals and further reduced by exercise. The apparent differences in the degree of response between slice areas and ventricular weights could be related to the regional nature of major responses (predominantly in the infarct zone) as well as to the possibility that events occurred in large part at the minor equator and were insufficient to promote proportional changes in total ventricular weight. The observed striking decrease in epicardial area in the infarct zone without change in infarct size might relate in part to global thinning of the LV wall, but it seems more likely that subendocardial scar formation prevented substantial stretch of the outer wall of the infarct region, because the infarcted wall was not significantly thinner after exercise. Therefore, the probable explanation for our findings is that propranolol inhibited the regional hypertrophic response to exercise observed in the untreated animals. It should be pointed out that we fixed the hearts at a common LV filling pressure of 10 mm Hg to compare LV morphologies in different groups. It is likely, however, that the filling pressures were higher in vivo, particularly after P3-blockade with exercise, and if the hearts had been fixed at in vivo pressures, the changes in chamber size and wall thickness probably would have been even larger.
Potential Clinical Implications
The results of this study cannot be directly compared with the clinical setting in patients who have received reperfusion therapy for acute myocardial infarction. The beneficial effects of long-term /3-blocker treatment after acute myocardial infarction to reduce mortality and nonfatal reinfarction in many large clinical trials1-6 may appear discordant with our findings, which postulate a detrimental effect, but thrombolysis was not carried out in the large clinical trials on /3-blockade after acute myocardial infarction, and the beneficial effects occurred primarily in high-risk patients.1-6 In the presence of thrombolysis, P-blockade has been reported to have no effect on LV function but to reduce early mortality by prevention of cardiac rupture.32 In a report from the Thrombolysis in Myocardial Infarction II-B study, in which thrombolysis was used in combination with /3-blockade in patients with acute myocardial infarction,7 no decreases in mortality or incidence of cardiac rupture were demonstrated with /-blockade, nor was there an effect on LV function; however, some benefit was noted on recurrent chest pain and reinfarction in the first week.7 Our animal model of nontransmural myocardial infarction with reperfusion might be considered to resemble the setting of the low-risk patient undergoing reperfusion of an occluded vessel without disease in other coronary arteries.
Exercise training after myocardial infarction combined with /3-blockade use might cause detrimental effects by limiting exercise-induced hypertrophy in the normal and infarcted regions, leading to further LV dilation, as in our animal model. However, clinical studies in a similar patient population would be needed before such an extrapolation could be made, and many other factors such as the duration of training, timing and dose of /3-blockade therapy, and presence or absence of coronary disease in other vessels would require consideration.
